1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Safety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Although antidepressant (AD) monotherapy is recommended first-line for major depressive disorder (MDD), AD + AD co-treatment is common.

          Related collections

          Author and article information

          Journal
          Expert Opin Drug Saf
          Expert opinion on drug safety
          1744-764X
          1474-0338
          Oct 2015
          : 14
          : 10
          Affiliations
          [1 ] a 1 The Zucker Hillside Hospital, Psychiatry Research, North Shore - Long Island Jewish Health System , Glen Oaks, NY, USA +1 71 84 70 48 12 ; +1 71 83 43 16 59 ; ccorrell@lij.edu.
          [2 ] b 2 Institut d'Ássistència Sanitària, Hospital de Santa Caterina , Salt, Spain.
          [3 ] c 3 Vanderbilt Psychiatric Hospital , Nashville, TN, USA.
          [4 ] d 4 Dainippon Sumitomo Pharma Co, Ltd , Osaka, Japan.
          [5 ] e 5 Hofstra North Shore LIJ School of Medicine , Hempstead, NY, USA.
          [6 ] f 6 The Feinstein Institute for Medical Research , Manhasset, NY, USA.
          [7 ] g 7 Albert Einstein College of Medicine , Bronx, NY, USA.
          Article
          10.1517/14740338.2015.1085970
          26360500
          0afb6f96-b3db-4c2c-a143-cfcc1feddef4
          History

          adverse effects,antidepressant,augmentation,co-treatment,combination,depression,major depressive disorder,meta-analysis,safety,tolerability

          Comments

          Comment on this article